Fig. 6
From: Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
Cell-cycle and apoptosis analyses of RCC cell transfectants treated with the combination. A–F: Transfectants (EV, HAS3) were treated with SF and MU combination, as indicated. Treated cells were analyzed for cell cycle progression and cell-cycle phase markers (A, B, E, and F) and for apoptosis and related markers (C–F). Data in A–D: Mean ± SD (n = 3). Please note that for brevity and clarity p values are shown for those pairs where the difference is statistically significant. In panels E and F actin is the loading control. The images are cropped for brevity. Uncropped images of the blots shown in panels E and F are provided in the Additional file 1 (Appendix)